Diltiazem Hydrochloride Injection, Solution
Product Images NDC 55150-425

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 55150-425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel-25 mg Per 5 mL (5 mg/ml) (Container Label)

Package Label-principal Display Panel-25 mg Per 5 mL (5 mg/ml) (Container Label)
This is a medication label indicating the NDC (National Drug Code), dosage information, storage directions, and manufacturer information for a medication administered through intravenous bolus injection or continuous infusion. It also includes the manufacturing date, expiration date, and lot number.*
FDA Label Image

Package Label-principal Display Panel-25 mg Per 5 mL (5 mg/ml) (Container-Carton)

Package Label-principal Display Panel-25 mg Per 5 mL (5 mg/ml) (Container-Carton)
This is a description of a medication called "Diltiazem" provided in a 10 x 5 mL Single-Dose Vials package, manufactured by Eugia USLLC. The medication is sterile, and each 5 mL vial contains 25 mg of Diltiazem in injection form. It is a prescription drug that should be used for Intravenous Bolus Injection and Continuous Intravenous Infusion. The medication should be stored at 2° to 8°C. Unused vials should be discarded. The package includes instructions for use, storage, and disposal, as well as details about the manufacturer and drug codes.*
FDA Label Image

Package Label-principal Display Panel-50 mg Per 10 mL (5 mg/ml) (Container Label)

Package Label-principal Display Panel-50 mg Per 10 mL (5 mg/ml) (Container Label)
This is a medication label for a single-dose vial containing 50 mg of an unspecified drug per 10 mL. The manufacturer Eugia US LLC is located in E. Windsor, NJ, and the product was made in India. The dosage and specific drug are not provided, so further information would need to be obtained from the package insert. There are instructions to discard any unused portion of the medication and to only use it for direct intravenous bolus injection or continuous intravenous infusion. The vial is sterile and should be discarded by a certain date, which is not given.*
FDA Label Image

Package Label-principal Display Panel-50 mg Per 10 mL (5 mg/ml) (Container-Carton)

Package Label-principal Display Panel-50 mg Per 10 mL (5 mg/ml) (Container-Carton)
This appears to be a medication label for Diltiazem, which is commonly used to treat high blood pressure and chest pain. It contains information on dosage, storage instructions, and potential side effects. The label specifies that the medication should be injected intravenously and that unused portions should be discarded. It also includes details about the specific formulation for this medication, such as the presence of citric acid and sodium citrate.*
FDA Label Image

Package Label-principal Display Panel-125 mg Per 25 mL (5 mg/ml) (Container Label)

Package Label-principal Display Panel-125 mg Per 25 mL (5 mg/ml) (Container Label)
This is a description for Diltiazem HCI Injection, which is a prescription drug that comes in a single-dose vial of 25 mL containing 125 mg of 5 mg/mL solution, manufactured in India for Eugia US LLC. It is recommended to store it in the fridge at a temperature between 2-8°C (36-46°F) and not freeze it. After being removed from the fridge, it should be discarded after a month if it's left at room temperature. It can be used for direct intravenous bolus injection and continuous intravenous infusion. The package insert should be consulted for the usual dosage, and any unused portion should be discarded.*
FDA Label Image

Package Label-principal Display Panel-125 mg Per 25 mL (5 mg/ml) (Container-Carton)

Package Label-principal Display Panel-125 mg Per 25 mL (5 mg/ml) (Container-Carton)
This is a description of Diltiazem HCl Injection, used for direct intravenous bolus injection and continuous intravenous infusion. It comes in 10 single-dose vials, each containing 125 mg per 25 mL (5 mg/mL) of Diltiazem HCl. The vials must be stored under refrigeration and any unused portions must be discarded. The usual dosage is specified in the package insert. The product is manufactured by Eugia US LLC, and the stopper of the vial does not contain natural rubber latex. The rest of the text is gibberish and does not provide any useful information.*
FDA Label Image

Diltiazem-structure (Diltiazem Str)

Diltiazem-structure (Diltiazem Str)
This text is not available as it consists of only chemical equations and abbreviations. It is not easily comprehensible or useful for a human reader without any context.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.